Revolutionizing drug discovery with stem cell technology, 18—19 January 2010, GlaxoSmithKline, Stevenage, UK
This Focused Meeting aims to brought together academics and colleagues from industry to address the state of the art in the biology of pluripotent stem cells and in particular the progress which has been made toward generating differentiated cell types from human embryonic stem cells that are of greatest potential significance in the process of drug discovery (neuronal cells, cardiomyocytes, hepatocytes). The meeting was of great interest to scientists in both academic and industrial sectors, providing an opportunity to discuss important aspects relating to the application of stem cells. View gallery...